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Table	of	Contents	Low	 complexity	 regions	 (LCRs)	 are	 strikingly	 simple	 sequences	where	 only	 a	 limited	number	of	amino	acids	is	repeated.	While	LCRs	are	quite	common,	their	high-resolution	characterization	 is	 inherently	 difficult.	Here	we	present	 Site-Specific	 Isotopic	 Labeling	(SSIL)	 as	 a	 powerful	 tool	 to	 study	 these	 intriguing	 sequences	 and	 shed	 light	 on	 their	structure/function	relationships.	 	
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Abstract	Remarkable	 technical	 progress	 in	 the	 area	 of	 structural	 biology	has	 paved	 the	way	 to	study	previously	inaccessible	targets.	For	example,	large	protein	complexes	can	now	be	easily	 investigated	 by	 cryo-electron	microscopy,	 and	modern	 high-field	NMR	magnets	have	 challenged	 the	 limits	 of	 high-resolution	 characterization	 of	 proteins	 in	 solution.	However,	the	structural	and	dynamic	characteristics	of	certain	proteins	with	important	functions	 still	 cannot	 be	 probed	by	 conventional	methods.	 These	 proteins	 in	 question	contain	low	complexity	regions	(LCRs),	compositionally	biased	sequences	where	only	a	limited	 number	 of	 amino	 acids	 is	 repeated	 multiple	 times,	 which	 hamper	 their	characterization.	 This	Concept	 article	 describes	 a	 Site-Specific	 Isotopic	 Labeling	 (SSIL)	strategy,	 which	 combines	 nonsense	 suppression	 and	 cell-free	 protein	 synthesis	 to	overcome	 these	 limitations.	 An	 overview	 on	 how	 poly-glutamine	 tracts	 were	 made	amenable	 to	 high-resolution	 structural	 studies	 is	 used	 to	 illustrate	 the	 usefulness	 of	SSIL.	Furthermore,	we	discuss	the	potential	of	this	methodology	to	give	further	insights	into	the	roles	of	LCRs	in	human	pathologies	and	liquid-liquid	phase	separation,	as	well	as	the	challenges	that	must	be	addressed	in	the	future	for	the	popularization	of	SSIL.		
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Introduction	Nuclear	 Magnetic	 Resonance	 (NMR)	 is	 the	 best-adapted	 technique	 to	 derive	 high-resolution	structural	and	dynamic	information	of	proteins	in	solution.	A	prerequisite	for	the	NMR	characterization	of	proteins	in	solution	is	the	production	of	isotopically	labeled	(15N	or	15N/13C)	samples,	which	is	normally	achieved	by	recombinant	overexpression	in	bacteria[1].	Although	 less	popular,	 eukaryotic	 cells	 and	 in	vitro	 expression	 systems	are	nowadays-available	 tools	 for	 protein	 production[2–4].	 Obtaining	 an	 (almost)	 complete	NMR	 assignment	 of	 a	 protein	 relies	 on	 our	 capacity	 to	 discriminate	 between	 similar	frequencies	 (chemical	 shifts),	 which	 depend	 on	 the	 environment	 that	 each	 individual	nucleus	experiences.	Specifically	designed	NMR	pulse	sequences	and	the	availability	of	high	magnetic	fields	enable	the	straightforward	assignment	of	proteins	up	to	40	kDa[5].	This	 also	 applies	 to	 Intrinsically	 Disordered	 Proteins	 (IDPs)	 that	 display	 reduced	 1H	dispersion	due	to	the	lack	of	permanent	secondary	or	tertiary	structure	(Fig.	1b)[6–8].	For	large	 IDPs,	 the	 use	 of	 high	 dimensionality	 or	 carbon-detected	 experiments	 enhances	spectral	resolution,	notably	simplifying	the	assignment	process[9–11].	Low	 Complexity	 Regions	 (LCRs)	 in	 proteins	 represent	 a	 challenge	 for	 the	 above-mentioned	NMR	 strategies.	 LCRs	 are	 compositionally	 biased	protein	 sequences	where	one	or	more	amino	acids	 are	 repeated	multiple	 times[12,13].	Different	LCR	patterns	are	known,	ranging	from	homo-repeats	(HRs)	(Fig.	1a,	right	panel),	in	which	one	amino	acid	is	consecutively	appearing	multiple	times[14,15],	to	tandem	repeats,	large	compositionally	unbiased	 fragments	 repeated	 several	 times[16,17].	 In	 LCRs,	 the	 chemical	 environment	experienced	by	some	nuclei	along	 the	sequence	 is	very	similar	or	equivalent	and,	as	a	consequence,	their	NMR	frequencies	overlap,	hampering	the	sequential	assignment.	This	phenomenon	 can	 be	 alleviated	 when	 repeats	 are	 not	 perfect,	 as	 the	 chemical	 shift	perturbation	 expands	 to	 a	 few	 residues	 on	 both	 sides.	 When	 LCRs	 adopt	 a	 fully	 or	partially	 folded	 structure,	 the	 chemical	 environment	 experienced	 by	 the	 nuclei	 is	 less	efficiently	averaged	and	some	chemical	dispersion	is	observed[18].	This	is	the	case	for	the	1H-15N	 Heteronuclear	 Single	 Quantum	 Correlation	 (15N-HSQC)	 experiment	 in	 a	huntingtin	construct	with	16	consecutive	glutamines	(see	Figure	1c,e)	and	the	androgen	receptor,	 where	 an	 elongated	 density	 of	 peaks	 appears	 in	 the	 15N-HSQC	 due	 to	 the	formation	 of	 a	 transient	 α-helix[18–20].	 Even	 under	 these	 circumstances,	 when	 the	number	of	consecutive	residues	 increases	 further,	 the	dispersion	 induced	by	structure	
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formation	is	not	enough	to	yield	isolated	peaks	(see	Fig.	1d,f	for	a	huntingtin	construct	with	46	consecutive	glutamines).	As	a	consequence	of	this	degeneracy	of	frequencies,	it	is	 impossible	to	obtain	high-resolution	information	of	LCRs	and	the	structural	bases	of	their	biological	function	cannot	be	unveiled.	Site-Specific	 Isotopic	 Labeling	 (SSIL),	 also	 named	 Site-Directed	 Isotopic	 Labeling	(SDIL)[21],	 provides	 a	 solution	 to	 the	 signal	 overlap	 problem	 in	 LCRs	 by	 introducing	 a	single	 isotopically	 labeled	 residue	 into	 the	 sequence,	 dramatically	 reducing	 the	complexity	 of	 the	 NMR	 spectra.	 This	 strategy	 is	 straightforward	 when	 employing	traditional	 solid	 phase	 peptide	 synthesis	 and	 commercial	 Boc-	 or	 Fmoc-protected	isotopically	 labeled	 amino	 acids[22,23].	 In	 an	 elegant	 example	 of	 SSIL,	 several	 collagen-derived	 peptides	 containing	 ten	 consecutive	 copies	 of	 the	 proline-hydroxyproline-glycine	tri-peptide	(POG)10	were	synthesized	by	moving	the	position	of	a	single	15N-Gly	within	 the	 chain,	 extremely	 simplifying	 resulting	 NMR	 spectra[23].	 Using	 this	 strategy,	the	dynamics	and	the	effects	of	mutations[24,25]	and	phosphorylation[26]	on	the	structure	and	 stability	 of	 the	 collagen	 triple	 helix	 were	 investigated.	 However,	 the	 systematic	application	of	SSIL	using	peptide	synthesis	strategies	presents	several	limitations,	such	as	the	cost	of	the	protected	isotopically	labeled	amino	acids,	the	length	of	the	peptides	amenable	 to	 peptide	 synthesis,	 and	 the	 presence	 of	 contaminants	 when	 this	 length	increases.	In	this	Concept	article	we	will	describe	the	coupling	of	SSIL	to	the	biochemical	production	 of	 proteins	 as	 an	 efficient	 strategy	 to	 overcome	 the	 above-mentioned	limitations.	 Then,	 some	 examples	 of	 potential	 applications	 of	 SSIL	 to	 address	biomedically	 relevant	 questions	 and	 the	 remaining	 challenges	 of	 the	 approach	will	 be	discussed.		
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Figure	1.	Compositional	bias	and	frequency	dispersion	in	NMR.	(a)	Cartoon	representation	of	
an	aperiodic	compositionally	unbiased	sequence	(left)	and	a	homo-repeat	(right).	Amino	acid	types	
are	represented	with	different	colors.	(b)	15N-HSQC	spectrum	of	the	79-amino	acid	long	C-terminal	
tail	of	the	β2	GPCR,	an	IDP	with	an	unbiased	composition,	displaying	a	good	peak	dispersion	that	
enables	 straightforward	 NMR	 frequency	 assignment.	 15N-HSQC	 spectra	 of	 huntingtin	 exon1	
containing	 16	 (c)	 and	 46	 (d)	 consecutive	 glutamines	 in	 the	 Poly-Q	 homo-repeat.	 A	 zoom	 of	 the	
glutamine	region	for	both	huntingtin	versions	is	displayed	in	panels	(e)	and	(f)	with	the	same	color	
code	 as	 in	 panels	 (c)	 and	 (d).	 Notice	 that	 the	 capacity	 to	 discriminate	 between	 the	 different	
glutamine	peaks	is	compromised	when	the	length	of	the	homo-repeat	increases.			
Nonsense	suppression	for	unnatural	and	natural	amino	acids	The	general	method	for	incorporating	non-canonical	(or	unnatural)	amino	acids	(ncAAs)	into	 proteins	 in	 vivo	 is	 based	 on	 the	 nonsense	 suppression	 strategy[27,28].	 This	methodology	uses	a	nonsense	suppressor	tRNACUA	that	recognizes	the	amber	stop	codon	(UAG)	in	the	protein-encoding	mRNA	and	elongates	the	nascent	peptide	chain	with	the	ncAA	previously	 loaded	 to	 the	 tRNACUA.	To	charge	 the	 tRNACUA	with	 the	desired	ncAA,	several	 mutant	 aminoacyl-tRNA	 synthetases	 (mut-aaRSs)	 have	 been	 engineered	 to	selectively	 recognize	 the	 ncAA	 and	 the	 corresponding	 tRNACUA[29].	 To	 prevent	 non-specific	charging	of	the	tRNAs,	these	tRNACUA/mut-aaRS	pairs	have	to	be	orthogonal	to	all	 endogenous	 tRNA/aaRS	 pairs	 of	 the	 host	 cells.	 In	 practice,	 E.	 coli	 cells	 are	 co-transformed	 with	 a	 plasmid	 coding	 for	 the	 tRNACUA/mut-aaRS	 pair,	 and	 a	 second	plasmid,	 coding	 for	 the	 protein	 of	 interest,	 containing	 an	 amber	 stop	 codon	 at	 the	desired	position.	Cells	are	then	grown,	and	upon	induction	in	presence	of	the	unnatural	amino	acid,	the	ncAA	is	incorporated	into	the	protein.	
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In	 order	 to	 apply	 this	 strategy	 to	 introduce	 isotopically	 labeled	natural	 (or	 canonical)	amino	 acids,	 the	 process	 of	 tRNACUA	 loading	 has	 to	 be	 done	 in	 isolation	 in	 vitro	 (see	below),	 because	 aaRSs	 cannot	 distinguish	 between	 an	 isotopically	 labeled	 and	 a	 non-labeled	natural	amino	acid.	The	loaded	tRNACUA	is	then	added	to	a	cell-free	(CF)	system	where	 the	 target	 protein	 is	 produced.	 CF	 is	 an	 in	 vitro	 protein	 synthesis	 method	composed	 of	 a	 lysate	 containing	 the	 transcription-translation	 machinery,	 normally	obtained	 from	 Escherichia	 coli	 cultures,	 which	 is	 supplemented	 with	 amino	 acids,	nucleotides,	salts	and	an	energy	regeneration	system	(Fig.	2)[20,21,28,30,31].	It	is	important	to	 mention	 that,	 once	 used,	 the	 tRNACUA	 cannot	 be	 reloaded	 inside	 the	 CF	 reaction,	making	this	process	a	one-off	reaction.			
	
Figure	2.	Scheme	of	 the	cell-free	synthesis	 for	SSIL.	A	combination	of	three	elements	produces	
the	 desired	 sample	 where	 a	 single	 isotopically	 amino	 acid	 is	 incorporated	 into	 the	 protein,	
dramatically	reducing	the	complexity	of	the	NMR	spectra.	The	in	vitro	cell-free	reaction,	containing	
the	E.	coli	transcriptional	and	translational	machineries,	is	supplied	with	amino	acids,	nucleotides,	
an	 energy	 regeneration	 system	 and	 other	 chemicals	 for	 efficient	 protein	 production.	 A	 second	
element	required	for	SSIL	is	a	plasmid	coding	for	the	protein	of	interest	with	an	amber	stop	codon	
(TAG)	 in	 the	position	 that	 is	 to	be	structurally	 investigated.	Finally,	a	 tRNA	with	 the	appropriate	
anticodon	(CUA)	and	the	isotopically	labeled	canonical	amino	acid	(represented	by	a	green	dot)	is	
also	added	to	the	CF	reaction.	This	figure	was	adapted	from	Urbanek	et	al.[20].		
Strategies	to	load	tRNACUA	Three	different	strategies	have	been	described	to	load	the	tRNACUA	in	vitro	(Fig.	3):	
The	 semisynthetic	 approach:	 This	 strategy	 uses	 an	 in	 vitro	 translated,	 truncated	tRNACUA,	 lacking	 the	 last	 two	nucleotides	of	 the	3’-end.	Then,	a	chemically	synthesized	aminoacylated	 dinucleotide	 is	 ligated	 to	 the	 truncated	 tRNACUA	 with	 a	 T4-RNA	 ligase	(Fig.	3a)[28,32].	This	method	is	very	versatile	and	can	be	used	to	attach	any	type	of	amino	acid	to	any	type	of	tRNACUA.	It	has	been	widely	used	in	the	past,	prior	to	the	emergence	of	the	in	vivo	system.	In	a	pioneering	example,	the	semisynthetic	approach	was	used	to	
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load	a	tRNACUA	with	a	13C-Alanine,	yielding	a	highly	simplified	13C-filtered	1H	spectrum	of	T4	 lysozyme	 in	 native	 and	 denaturing	 conditions[30].	 More	 recently,	 the	 Green	Fluorescent	Protein	 (GFP)	was	produced	with	 a	 single	 13C,18O-tyrosine[31].	 The	 sample	enabled	 the	 recording	 of	 time-resolved	 infrared	 absorption	 spectra	 in	 a	 site-specific	manner	 and	 yielded	 novel	 information	 on	 the	 photodynamics	 of	 GFP.	 Despite	 these	successful	examples,	when	aiming	to	use	isotopically	labeled	canonical	amino	acids,	the	synthesis	of	 large	quantities	of	 the	aminoacylated	dinucleotides	presents	an	 important	bottleneck.	
Flexizyme:	 This	 method	 uses	 in	 vitro	 transcribed	 full-length	 tRNACUA,	 an	 excess	 of	flexizyme	 (a	 specifically	 designed	 ribozyme),	 and	 an	 activated	 version	 of	 the	 desired	amino	acid,	 for	 example	 the	dinitrobenzylester	derivative	 (Fig.	3b)[33].	 Similarly	 to	 the	semisynthetic	 approach,	 the	 flexizyme	 strategy	 is	 very	 versatile	 in	 terms	 of	 chosen	amino	acids	and	tRNAs,	although	the	acylation	times	and	efficiencies	are	highly	amino	acid	 dependent,	 ranging	 from	 2-72	 hours	 and	 17-91%,	 respectively[33].	 The	 chemical	activation	of	 the	amino	acid	 is	probably	 the	main	 limitation	 for	 the	application	of	 this	methodology	in	SSIL.		
Use	 of	 purified	 aminoacyl-synthetases:	 Here	 the	 in	 vitro	 transcribed	 full-length	tRNACUA	 is	mixed	with	 catalytic	 amounts	 of	 the	 cognate	 aaRS,	 the	 isotopically	 labeled	amino	acid	and	a	buffer	containing	ATP,	resulting	in	nearly	full	turnover	in	less	than	one	hour	 (Fig.	3c).	The	most	 important	advantage	of	 this	methodology	with	 respect	 to	 the	previously	mentioned	ones	 is	 the	direct	use	of	any	commercially	available	 isotopically	labeled	natural	amino	acid.	As	previously	mentioned,	 the	 tRNACUA/aaRS	pair	has	 to	be	orthogonal	to	the	CF	system	used,	and	pairs	from	other	organisms	may	be	adapted	for	this	reason.	The	relevance	of	this	point	is	exemplified	by	the	pioneering	study	by	Yabuki	
et	al.	 [21],	who	managed	to	isotopically	label	a	single	tyrosine	in	a	protein	by	SSIL	using	the	endogenous	E.	coli	TyrRS.	However,	as	a	 consequence	of	 the	 lack	of	orthogonality,	the	isotopic	 labeling	yield	was	only	50%,	and	the	reaction	time	had	to	be	optimized	to	minimize	the	undesired	loading	of	the	tRNACUA	with	unlabeled	tyrosine.		Overall,	 all	 these	 methods	 allow	 the	 specific	 aminoacylation	 of	 the	 chosen	 tRNACUA.	Whereas	the	semisynthetic	and	the	flexizyme	approach	may	be	preferable	when	applied	to	 novel	 ncAAs	 without	 their	 corresponding	 engineered	 mut-aaRSs,	 enzymatic	
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aminoacylation	 is	 more	 efficient	 and	 cost	 effective	 when	 incorporating	 isotopically	labeled	natural	amino	acids.	An	important	chemical	feature	of	loaded	tRNACUA	is	the	high	susceptibility	to	hydrolysis	of	the	phosphoester	bond	between	the	tRNACUA	and	the	amino	acid[34].	As	a	consequence	of	this	lability,	the	yield	of	suppressed	sample	with	respect	to	the	total	 input	of	 loaded	tRNACUA	is	relatively	low[20,31].	This	inherent	limitation	has	to	be	addressed	in	the	future	for	the	efficient	application	of	SSIL.		
	
Figure	3.	tRNA	loading	strategies.	(a)	Semisynthetic	approach.	A	truncated	tRNACUA,	lacking	the	
last	 two	 nucleotides	 of	 the	 3’-end	 is	 incubated	 with	 a	 chemically	 synthesized	 aminoacylated	
dinucleotide	 (cytidylyl	 (3'→5')	 adenosine	 5’-phosphates,	 pCpA)	 and	T4	RNA	 ligase,	 resulting	 in	 a	
full-length	 aminoacylated	 tRNACUA.	 (b)	 Flexizyme-mediated	 loading	 of	 tRNACUA.	Dinitro-flexizyme	
(dFx)	utilizes	3,5-dinitrobenzyl	 ester-activated	amino	acids	and	catalyzes	 the	 loading	of	 tRNACUA.	
(c)	 The	 aminoacyl-synthetase	 charges	 the	 suppressor	 tRNACUA	 with	 its	 cognate	 amino	 acid.	 R	
represents	in	principle	any	kind	of	side	chain.	Note	that	the	final	product	of	the	three	strategies	is	
the	same	molecule.		
Application	of	SSIL	to	study	the	glutamine	homo-repeat	in	huntingtin	We	 have	 recently	 demonstrated	 the	 use	 of	 SSIL	 to	 structurally	 characterize	 low	complexity	 regions	 using	 the	 huntingtin	 protein	 as	 model	 protein[20].	 The	 N-terminal	region	 of	 huntingtin,	 also	 known	 as	 exon1	 (httex1),	 is	 the	 causative	 agent	 of	Huntington’s	Disease	(HD),	a	deadly	neurodegenerative	pathology[35].	 Interestingly,	HD	develops	 when	 the	 number	 of	 consecutive	 glutamines	 in	 httex1	 exceeds	 35.	 The	
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structural	 bases	 of	 this	 pathological	 threshold	 remain	 poorly	 understood	 due	 to	 the	inherent	 problems	 that	 homo-repeats	 pose	 to	 traditional	 NMR	 approaches.	 Using	 a	GlnRS/tRNACUA	pair	derived	 from	yeast[36],	 five	glutamines	of	an	httex1	construct	with	16	consecutive	glutamines	(H16)	were	isotopically	labeled	with	yields	that	allowed	the	NMR	 investigation	 (≈10	 μM	 from	 5	 mL	 of	 CF	 reaction)[20].	 The	 resulting	 samples	provided	isolated	peaks	in	the	highly	congested	Poly-Q	region	of	the	15N-HSQC,	as	well	as	 in	 the	 side	 chain	 region	 (Fig.	 4a,b).	 Using	 13C-HSQC	 experiments,	 the	 Cα	 and	 Cβ	chemical	 shifts	 of	 the	 individual	 glutamines	were	 also	 precisely	measured,	 suggesting	that	 the	 Poly-Q	 tract	 is	 enriched	 in	 α-helical	 conformations,	 in	 line	 with	 previous	studies[19,37]	 (Fig.	 4c,d,f).	 Interestingly,	 the	 15N-HSQC	 of	 Q48	 displays	 a	 second	 low	intensity	peak	that	was	attributed	to	the	cis	conformation	of	the	neighboring	proline	49	(Fig.	4e).	The	strategy	was	also	successfully	applied	 to	a	pathological	httex1	construct	with	46	consecutive	glutamines,	demonstrating	the	generality	of	the	approach.	Although	only	 few	 positions	 were	 explored	 in	 this	 study,	 it	 demonstrates	 that	 the	 systematic	structural	investigation	of	homo-repeats	is	feasible.		
	
Figure	4.	Application	of	SSIL	to	study	the	glutamine	HR	in	huntingtin	protein	using	
NMR.	(a)	Overlay	of	the	15N-HSQC	spectrum	of	fully	labeled	H16	(grey)	with	those	of	five	
SSIL	 samples:	 Q20	 (blue),	 Q24	 (orange),	 Q28	 (red),	 Q32	 (purple)	 and	 Q48	 (magenta),	
focusing	 on	 the	 Poly-Q	 region.	 The	 same	 color	 code	 is	 used	 throughout	 the	 figure.	 (b)	
Zoomed	view	of	 the	15N-HSQC	spectra	showing	the	glutamine	side	chains.	 13C-HSQC	NMR	
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spectra	 showing	 the	 Cα	 (c)	 and	 the	 Cβ	 and	 Cγ	 (d)	 regions.	 (e)	 Overlay	 of	 the	 15N-HSQC	
spectra	of	fully	labeled	H16	and	Q48.	The	arrow	indicates	the	population	of	Q48	preceding	
the	 cis	 conformation	 of	 proline	 49.	 (f)	 Secondary	 chemical	 shift	 analysis	 using	 the	
extracted	Cα	and	Cβ	chemical	shifts	and	a	random-coil	library.	A	schematic	representation	
of	 httex1	 is	 shown	 to	 indicate	 the	different	domains,	 and	 the	positions	 of	 glutamine	and	
proline	residues	are	highlighted	in	yellow	and	blue,	respectively.	This	 figure	was	adapted	
from	Urbanek	et	al.[20].		
Applications	of	SSIL	SSIL	represents	a	unique	tool	to	access	high-resolution	information	of	biological	systems	that	cannot	be	characterized	by	traditional	means.	Here,	we	briefly	describe	two	cases	that	exemplify	the	kind	of	questions	that	could	be	addressed	with	SSIL.		
Functional	and	pathological	roles	of	homo-repeats	(HRs):	HRs,	which	are	abundant	in	eukaryotes[14,15,38],	represent	the	most	obvious	target	for	the	application	of	SSIL.	The	structural	 features	of	 these	homopolymeric	 regions	are	 largely	unknown	and	possible	structure/function	relationships	remain	to	be	deciphered.	This	is	especially	relevant	for	a	 family	 of	 diseases	 linked	 to	 the	pathological	 expansion	 of	 Poly-Q[39,40]	 and	Poly-A[41]	tracts,	 which	 lead	 to	 the	 formation	 of	 irreversible	 aggregates[42].	 Structural	perturbations	exerted	by	 these	abnormal	expansions	are	so	 far	unknown,	 limiting	our	understanding	 of	 the	 underlying	 pathological	 mechanism	 and	 their	 potential	remediation[43].	
Low	 Complexity	 Regions	 and	 Liquid-Liquid	 Phase	 Separation:	 A	 large	 body	 of	examples	 has	 identified	 LCRs	 inserted	 in	 some	 IDPs	 as	 the	 key	 elements	 for	 the	formation	 of	 membrane-less	 compartments	 in	 cells	 through	 a	 liquid-liquid	 phase	separation	(LLPS)	mechanism,	a	phenomenon	that	has	been	shown	to	be	fundamental	in	a	 myriad	 of	 biological	 processes[44,45][46].	 Although	 not	 exclusively,	 droplet-forming	sequences	 include	RG/RGG,	FG,	VPGV,	Y-containing	sequences	and	alternating	charged	blocks,	 which	 are	 able	 to	 establish	 multiple	 intermolecular	 low-affinity	 interactions.	Several	studies	have	focused	on	connecting	protein	sequences	to	their	capacity	to	phase-separate[47].	Unfortunately,	the	role	of	protein	structure	in	triggering	or	modulating	this	property	 is	 less	 clear.	 These	 structural	 investigations,	 too,	 are	 impaired	 by	 the	congestion	of	 the	NMR	spectra	of	LLPS-inducing	LCRs	that	worsens	within	droplets[48–50].	
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Future	challenges	of	SSIL	In	order	to	address	the	structural	questions	described	in	the	previous	sections,	several	challenges	will	have	to	be	addressed.	In	this	section	we	will	describe	those	that	we	think	are	the	most	relevant.	
Expanding	 the	 panel	 of	 amino	 acids	 amenable	 to	 SSIL:	 The	 high	 throughput	application	 of	 SSIL	 for	 structural	 purposes	 requires	 the	 use	 of	 scalable	 and	 highly	efficient	enzymatic	tRNACUA	loading	which,	for	the	moment,	has	only	been	developed	for	glutamine[20].	 Already	 existing	 orthogonal	 tRNACUA/aaRS	 pairs	 (for	 example	 for	aspartate[51],	glutamate[52],	leucine[53],	proline[54]	and	tyrosine[55])	may	be	adapted	to	this	purpose.	 In	 the	 future,	orthogonal	pairs	 for	 the	remaining	amino	acids	will	have	 to	be	found	and	validated	if	we	want	to	expand	the	range	of	applications	of	SSIL.	The	use	of	promiscuous	aaRSs	with	the	capacity	to	 load	similar	natural	amino	acids[56],	which	are	present	in	some	organisms,	can	be	a	simpler	way	to	expand	the	panel	of	amino	acids	for	SSIL.	
Increasing	 the	 number	 of	 labeled	 sites:	 Present	 approaches	 only	 allow	 the	incorporation	of	a	single	labeled	residue	within	a	protein	chain.	First,	there	is	a	limited	amount	 of	 loaded	 tRNACUA	 present	 in	 the	 reaction	 mixture	 due	 to	 the	 spontaneous	deacylation	of	the	tRNACUA	(see	above).	Note	that	for	ncAAs,	the	engineered	aaRS	can	be	added	 to	 the	 reaction	mixture,	but	 this	 is	not	possible	when	 the	aim	 is	 to	 incorporate	natural	amino	acids.	Second,	there	is	a	systematic	decrease	of	the	translation	yield	when	incorporating	an	amino	acid	from	an	orthogonal	tRNACUA.	This	is	mainly	due	to	stalling,	which	 increases	 the	 probability	 of	 ribosome	 disassembly,	 and	 translation	 abortion	 by	the	 competitive	 action	 of	 release	 factor	 1	 (RF1).	 Several	 groups	 have	 proposed	approaches	 to	 inactivate	 or	 remove	 RF1	 from	 cell	 lysates	 (see	 ref	 [57]	 and	 references	therein).	 For	 example,	 Loscha	 et	 al.	 generated	 an	 RF1-chitin	 binding	 domain	 chimera	that	 can	be	 removed	during	 lysate	preparation,	which	enabled	 the	 incorporation	of	4-trifluoro-methyl	 phenylalanine	 in	 four	 positions	 of	 a	 protein[57].	 Alternatively,	 E.	 coli	strains	with	RF1	deletions	and	other	complementing	mutations	have	been	engineered	to	optimize	the	incorporation	of	multiple	ncAAs	without	compromising	the	final	yield[58–60].	However,	these	strategies	were	validated	with	ncAAs	and	their	corresponding	mut-aaRS	in	the	CF	mixture.	It	remains	to	be	demonstrated	whether	this	strategy	will	be	suitable	
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for	the	incorporation	of	isotopically	labeled	amino	acids	into	multiple	protein	sites	in	a	one-off	reaction.	
Incorporation	of	novel	ncAAs:	The	extensive	panel	of	ncAAs	and	their	corresponding	engineered	mut-aaRSs	that	have	been	developed	for	 in	vivo	 incorporation[27]	in	the	last	decades	 can	 be	 directly	 added	 to	 CF	 systems	 as	 recently	 demonstrated	 for	 the	incorporation	of	L-phosphoserine[61,62].	 If	 the	 loading	reaction	is	performed	separately,	as	 discussed	previously,	 semisynthetic	 and	 flexizyme	 strategies	 offer	 nearly	 unlimited	possibilities	regarding	the	nature	of	the	ncAA	used.	This	is	due	to	the	fact	that	the	latter	strategies	 are	 only	 limited	 by	 the	 stability	 of	 the	 ncAAs	 under	 the	 conditions	 of	 the	chemical	reactions	necessary	to	modify	the	amino	acid	and	load	the	tRNAs.	The	use	of	cognate	 aaRSs	 to	 load	 ncAAs	 is	 more	 limited	 but	 offers	 very	 interesting	 possibilities.	AaRS	 have	 evolved	 to	 be	 extremely	 specific	 for	 a	 single	 natural	 amino	 acid,	 thus	 the	tolerance	of	structural	modifications	is	restricted	and	only	small	chemical	changes	may	be	 allowed.	 We	 anticipate	 that	 modifications	 such	 as	 halogenation	 (especially	 with	fluorine),	hydroxylation,	or	methylation	could	be	incorporated	into	proteins	using	SSIL	without	engineering	the	aaRSs.	In	particular,	the	complete	control	over	the	experimental	conditions	of	 the	 loading	 reaction,	 including	 time,	 temperature,	pH	and	concentration,	may	help	to	load	such	ncAAs	onto	the	tRNACUA.	Since	the	SSIL	CF	reaction	can	be	tuned	and	 scaled-up	 easily,	 a	 loading	 of	 the	 tRNACUA	 of	 100%	 is	 not	 necessary	 to	 obtain	reasonable	amounts	of	labeled	protein	(unpublished	data).	Some	of	these	modifications	are	 extremely	 interesting	 from	 biological	 and	 biophysical	 perspectives.	 For	 example,	some	 amino	 acids	 are	 post-translationally	 methylated	 (arginine	 and	 lysine)	 or	hydroxylated	 (proline	and	 lysine),	playing	 important	 roles	 in	 signaling	and	regulation.	Moreover,	 fluorine	 is	 emerging	 as	 a	 very	 interesting	 probe	 to	 study	 protein	 structure	and	biomolecular	interactions,	thanks	to	the	very	interesting	features	of	19F-NMR[63,64].		
Concluding	Remarks	Recent	developments	in	structural	biology	allow	the	detailed	study	of	biomolecules	and	biological	processes	 that	were	not	possible	before.	However,	 there	are	 still	 families	of	biomolecules,	 such	as	LCRs,	 that	 cannot	be	structurally	and	dynamically	 characterized	with	 the	 present	 technology.	 SSIL,	 which	 allows	 the	 placement	 of	 isotopes	 in	 specific	positions	 within	 proteins,	 will	 enable	 the	 atomistic	 description	 of	 LCRs	 by	 NMR.	 The	
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general	availability	of	high-magnetic	fields	and	commercial	cold-probes,	which	enhance	NMR	 sensitivity,	 makes	 SSIL	 a	 very	 timely	 development	 that	 will	 complement	knowledge	 derived	 from	 traditional	 NMR	methodologies.	We	 believe	 that	 use	 of	 SSIL	will	 allow	 researchers	 to	 establish	 the	 structure/function	 relationships	 for	 biological	systems	 that	 could	 not	 be	 addressed	 before.	 This	 way,	 we	 expect	 to	 reach	 a	 deeper	understanding	 of	 biological	 processes	 with	 important	 medical	 and	 biotechnological	relevance.	However,	the	generalization	of	SSIL	must	be	necessarily	accompanied	by	the	implementation	of	 the	appropriate	technology	 in	research	 laboratories.	Surpassing	the	challenges	described	in	this	Concept	article	will	expand	the	range	of	applications	of	SSIL	and	facilitate	its	generalization.		
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